108 related articles for article (PubMed ID: 26750924)
1. An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis.
Singh S; Singh DB; Singh A; Gautam B; Ram G; Dwivedi S; Ramteke PW
Interdiscip Sci; 2016 Dec; 8(4):388-394. PubMed ID: 26750924
[TBL] [Abstract][Full Text] [Related]
2. Identification of potential antivirulence agents by substitution-oriented screening for inhibitors of Streptococcus pyogenes sortase A.
Wójcik M; Eleftheriadis N; Zwinderman MRH; Dömling ASS; Dekker FJ; Boersma YL
Eur J Med Chem; 2019 Jan; 161():93-100. PubMed ID: 30343193
[TBL] [Abstract][Full Text] [Related]
3. Molecular modeling and simulation of FabG, an enzyme involved in the fatty acid pathway of Streptococcus pyogenes.
Shafreen RB; Pandian SK
J Mol Graph Model; 2013 Sep; 45():1-12. PubMed ID: 23988477
[TBL] [Abstract][Full Text] [Related]
4. Metabolic pathway analysis of S. pneumoniae: an in silico approach towards drug-design.
Singh S; Malik BK; Sharma DK
J Bioinform Comput Biol; 2007 Feb; 5(1):135-53. PubMed ID: 17477495
[TBL] [Abstract][Full Text] [Related]
5. Core Proteomic Analysis of Unique Metabolic Pathways of Salmonella enterica for the Identification of Potential Drug Targets.
Uddin R; Sufian M
PLoS One; 2016; 11(1):e0146796. PubMed ID: 26799565
[TBL] [Abstract][Full Text] [Related]
6. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
7. In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against
Rehman A; Wang X; Ahmad S; Shahid F; Aslam S; Ashfaq UA; Alrumaihi F; Qasim M; Hashem A; Al-Hazzani AA; Abd Allah EF
Int J Environ Res Public Health; 2021 Oct; 18(21):. PubMed ID: 34769873
[No Abstract] [Full Text] [Related]
8. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
Anishetty S; Pulimi M; Pennathur G
Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
[TBL] [Abstract][Full Text] [Related]
9. Computational Identification of Essential Enzymes as Potential Drug Targets in
Narad P; Himanshu ; Bansal H
J Microbiol Biotechnol; 2021 Apr; 31(4):621-629. PubMed ID: 33323673
[No Abstract] [Full Text] [Related]
10. Identification of putative drug targets in Vancomycin-resistant Staphylococcus aureus (VRSA) using computer aided protein data analysis.
Hasan MA; Khan MA; Sharmin T; Hasan Mazumder MH; Chowdhury AS
Gene; 2016 Jan; 575(1):132-43. PubMed ID: 26319513
[TBL] [Abstract][Full Text] [Related]
11. In-silico Subtractive Proteomic Analysis Approach for Therapeutic Targets in MDR Salmonella enterica subsp. enterica serovar Typhi str. CT18.
Rahman N; Muhammad I; Nayab GE; Khan H; Filosa R; Xiao J; Hassan STS
Curr Top Med Chem; 2019; 19(29):2708-2717. PubMed ID: 31702501
[TBL] [Abstract][Full Text] [Related]
12. Protein interaction network analysis--approach for potential drug target identification in Mycobacterium tuberculosis.
Kushwaha SK; Shakya M
J Theor Biol; 2010 Jan; 262(2):284-94. PubMed ID: 19833135
[TBL] [Abstract][Full Text] [Related]
13. Exploration of fluoroquinolone resistance in Streptococcus pyogenes: comparative structure analysis of wild-type and mutant DNA gyrase.
Shafreen RM; Selvaraj C; Singh SK; Pandian SK
J Mol Recognit; 2013 Jun; 26(6):276-85. PubMed ID: 23595809
[TBL] [Abstract][Full Text] [Related]
14. Potential antibiotic and anti-infective effects of rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. on Streptococcus pyogenes as revealed by proteomics.
Limsuwan S; Hesseling-Meinders A; Voravuthikunchai SP; van Dijl JM; Kayser O
Phytomedicine; 2011 Aug; 18(11):934-40. PubMed ID: 21439802
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling on streptolysin-O of multidrug resistant Streptococcus pyogenes and computer aided screening and in vitro assay for novel herbal inhibitors.
Skariyachan S; Narayan NS; Aggimath TS; Nagaraj S; Reddy MS; Narayanappa R
Curr Comput Aided Drug Des; 2014 Mar; 10(1):59-74. PubMed ID: 24694051
[TBL] [Abstract][Full Text] [Related]
16. Sulfonamide resistance in Streptococcus pyogenes is associated with differences in the amino acid sequence of its chromosomal dihydropteroate synthase.
Swedberg G; Ringertz S; Sköld O
Antimicrob Agents Chemother; 1998 May; 42(5):1062-7. PubMed ID: 9593127
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the Rgg2 transcriptional regulator ablates the virulence of Streptococcus pyogenes.
Zutkis AA; Anbalagan S; Chaussee MS; Dmitriev AV
PLoS One; 2014; 9(12):e114784. PubMed ID: 25486272
[TBL] [Abstract][Full Text] [Related]
18. Subtractive genomics approach to identify putative drug targets and identification of drug-like molecules for beta subunit of DNA polymerase III in Streptococcus species.
Georrge JJ; Umrania VV
Appl Biochem Biotechnol; 2012 Jul; 167(5):1377-95. PubMed ID: 22415782
[TBL] [Abstract][Full Text] [Related]
19. Identification of potential drug targets in Yersinia pestis using metabolic pathway analysis: MurE ligase as a case study.
Sharma A; Pan A
Eur J Med Chem; 2012 Nov; 57():185-95. PubMed ID: 23059547
[TBL] [Abstract][Full Text] [Related]
20. Copper Tolerance and Characterization of a Copper-Responsive Operon, copYAZ, in an M1T1 Clinical Strain of Streptococcus pyogenes.
Young CA; Gordon LD; Fang Z; Holder RC; Reid SD
J Bacteriol; 2015 Aug; 197(15):2580-92. PubMed ID: 26013489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
